However, recent in vitro and in vivo studies have shown that RON expression or activation is altered in epithelial carcinomas including lung, colon, and breast cancers [6, 11–15], indicating that abnormal activation of this receptor may play a role in the progression of certain epithelial cancers. This evidence concerns the gene MST1R and breast cancer.